Nucala 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCFM1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,004
Award facts
- Contract value 100% obligated
- $21,004.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,004.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nucala 100 mg/mL syringes. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and was awarded on December 12, 2025. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group Inc. will perform the work at its facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, designated SPE2DR, which was awarded under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025. The underlying IDC carries a ceiling value of $499.999 billion with a completion date of December 31, 2036, and is structured as a 30-month base period with three 30-month option periods. Through this contract vehicle, DMS Pharmaceutical Group serves as a regional prime vendor contractor supplying a comprehensive range of pharmaceutical products, including branded and generic medications, biologics, and medical consumables, to support Department of Defense military healthcare facilities worldwide. The company has demonstrated substantial federal contracting capability through numerous delivery orders across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DR26FCFM1?
SPE2DR26FCFM1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FCFM1 worth?
The government has obligated $21,004 on SPE2DR26FCFM1.
Is contract SPE2DR26FCFM1 an order under another contract?
Yes. SPE2DR26FCFM1 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFM1 competed?
The extent of competition for SPE2DR26FCFM1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award